Journal Article (Review Article)

DKFZ-2026-02244

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png The State of the Art of Theranostics and Its Future.

Civan, C.DKFZ* ; Fendler, W. P.DKFZ* ; Küper, A.DKFZ* ; Bodei, L. ; Weber, W. A. ; Emmett, L. ; Herrmann, K.DKFZ*

2026
Soc. New York, NY

Abstract: Nuclear medicine has experienced several transformative developments in the past, including the introduction of PET and PET/CT imaging. However, nothing was more transformative than the recent resurrection of radionuclide therapy. Coined by a new term, theranostics, that underlines the ability to exploit the same target for imaging as well as therapy, radionuclide therapy has experienced tremendous attention and interest from patients, clinicians, and industry. This article summarizes the current state of theranostics and then provides an outlook on its short- and long-term future.

Keyword(s): Humans (MeSH) ; Nuclear Medicine: trends (MeSH) ; Theranostic Nanomedicine: trends (MeSH) ; Theranostic Nanomedicine: methods (MeSH) ; Radiopharmaceuticals: therapeutic use (MeSH) ; nuclear medicine ; radionuclide therapy ; radiopharmaceuticals ; theranostics ; Radiopharmaceuticals

Note: #DKTKZFB9#

---

Contributing Institute(s):

1. DKTK Koordinierungsstelle Essen/Düsseldorf (ED01)

Research Program(s):

1. 899 - ohne Topic (POF4-899) (POF4-899)

Appears in the scientific report 2026

---

Database coverage:
; BIOSIS Previews ; Biological Abstracts ; Clarivate Analytics Master Journal List ; Current Contents - Clinical Medicine ; Current Contents - Life Sciences ; Essential Science Indicators ; IF >= 5 ; JCR ; PubMed Central ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection

---